Precision Immunotherapeutics Limited
- Company number
- 11663294
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 6 Nov 2018
- Nature of business
- Research and experimental development on biotechnology
Registered office
Previous names
- Precision Therapeutics Limited (until 5 Dec 2018)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SELF, Colin Henry, Professor | Director | 6 Nov 2018 | |
| CUNNINGHAM, Declan Thomas | Director | 6 Nov 2018 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Peter Self | Ownership Of Shares 25 To 50 Percent | 25 Nov 2025 | |
| Dr David Self | Ownership Of Shares 25 To 50 Percent | 25 Nov 2025 | |
| Dr Alexander Self | Ownership Of Shares 25 To 50 Percent | 25 Nov 2025 | |
| Professor Colin Henry Self | Ownership Of Shares 75 To 100 Percent Voting Rights 50 To 75 Percent |
6 Nov 2018 | 25 Oct 2025 |
| Mr William Gwyn Cole | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
6 Nov 2018 | 10 Sep 2025 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 30 Nov 2025 | -£20,339 | - | 0 |
| 30 Nov 2024 | £13,862 | - | 0 |
| 30 Nov 2023 | £11,853 | - | 0 |
| 30 Nov 2022 | - | - | 0 |
| 30 Nov 2021 | - | - | 0 |
| 30 Nov 2020 Dormant | £1 | £1 | - |
| 30 Nov 2019 Dormant | £1 | £1 | - |
Connections
Directors’ other companies
- CUNNINGHAM, Declan Thomas - Director at Selective Antibodies Limited
- SELF, Colin Henry, Professor - Director at Selective Antibodies Limited